首页> 外文期刊>World Journal of Gastroenterology >Predictors of esophageal varices and first variceal bleeding in liver cirrhosis patients
【24h】

Predictors of esophageal varices and first variceal bleeding in liver cirrhosis patients

机译:肝硬化患者食管静脉曲张和首次曲张静脉出血的预测因素

获取原文
           

摘要

AIMTo assess “predictors” of esophageal varices (EV) and variceal bleeding using non-invasive markers in Albanian patients diagnosed with liver cirrhosis. METHODSOne hundred thirty-nine newly diagnosed cirrhotic patients without variceal bleeding were included in this analysis. Model for end-stage liver disease (MELD), aspartate aminotransferase (AST) to alanine aminotransferase (ALT) ratio (AST/ALT), AST to platelet ratio index (APRI), platelet count to spleen diameter (PC/SD), ?brosis-4-index (FIB-4), fibrosis index (FI) and King’s Score were measured for all participants. All patients underwent endoscopic assessment within two days of hospitalization. The major end point was the first esophageal variceal bleeding (EVB) event. The diagnostic performance of “predictors” for the presence of EV and EVB were assessed by sensitivity and specificity values obtained from the receiver operating characteristics procedure. RESULTSFIB-4 was the only strong and significant “predictor” of esophageal varices (multivariable-adjusted OR = 1.57 for one unit increment; 95%CI: 1.15-2.14). Furthermore, a cut-off value of 3.23 for FIB-4 was a significant predictor of esophageal varices, with a sensitivity of 72%, a specificity of 58% and a proportion of area under the curve (AUC) of 66% (P = 0.01). During the follow-up (median: 31.5 mo; interquartile range: 11-59 mo), 34 patients (24%) experienced a first EVB. FIB-4 was a poor predictor of EVB (the AUC was only 51%) for a cut-off value of 5.02. Furthermore, the AUC of AST/ALT, APRI, PC/SD, FI, MELD and King's Score ranged from 45% to 55%. None of the non-invasive markers turned out to be a useful predictor of EVB. CONCLUSIONDespite the low diagnostic accuracy, FIB-4 appears the most efficient non-invasive liver fibrosis marker which can be used as an initial screening tool for cirrhotic patients.
机译:目的使用非侵入性标记物评估诊断为肝硬化的阿尔巴尼亚患者的食道静脉曲张(EV)和静脉曲张破裂出血的“预测因素”。方法139例新诊断为肝硬化的患者,无静脉曲张破裂出血。终末期肝病(MELD),天冬氨酸转氨酶(AST)与丙氨酸转氨酶(ALT)之比(AST / ALT),AST与血小板之比指数(APRI),血小板与脾脏直径之比(PC / SD),测量了所有参与者的brosis-4-指数(FIB-4),纤维化指数(FI)和King's Score。所有患者均在住院两天内接受了内镜检查。主要终点是第一次食管静脉曲张破裂出血(EVB)事件。 EV和EVB存在的“预测因子”的诊断性能通过从接收器工作特性程序获得的灵敏度和特异性值进行评估。 RESULTSFIB-4是食管静脉曲张的唯一强而有力的“预测因素”(多变量调整后OR = 1.57,单位递增; 95%CI:1.15-2.14)。此外,FIB-4的截止值为3.23是食管静脉曲张的重要预测指标,敏感性为72%,特异性为58%,曲线下面积(AUC)的比例为66%(P = 0.01)。在随访期间(中位数:31.5 mo;四分位间距:11-59 mo),有34例患者(24%)经历了第一次EVB。 FIB-4不能很好地预测EVB(AUC仅为51%),临界值为5.02。此外,AST / ALT,APRI,PC / SD,FI,MELD和King's Score的AUC介于45%至55%之间。没有一种非侵入性标志物被证明是EVB的有用预测指标。结论尽管诊断准确性低,但FIB-4似乎是最有效的非侵入性肝纤维化标记物,可作为肝硬化患者的初始筛查工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号